Targeting Triple-Negative Breast Cancer
March 14, 2016
In this interview we discuss the current challenges to treating triple-negative breast cancer and look at avenues of promising research.
Joyce O'Shaughnessy, MD
MBCC: Emerging Therapies for Triple-Negative Breast Cancer
March 13, 2012
Triple-negative breast cancer is aggressive, has a high rate of metastases, and carries a poor prognosis. Dr. Joyce O’Shaughnessy, who will be presenting at the Miami Breast Cancer Conference, discusses an overview of new therapies for triple-negative breast cancer.
